
1 Safe-and-Steady Stock to Consider Right Now and 2 to Be Wary Of
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here is one low-volatility stock that could offer consistent gains and two that may not deliver the returns you need.
Two Stocks to Sell:
CONMED (CNMD)
Rolling One-Year Beta: 0.17
With over five decades of experience in surgical innovation since its founding in 1970, CONMED (NYSE:CNMD) develops and manufactures medical devices and equipment for surgical procedures, specializing in orthopedic and general surgery products.
Why Does CNMD Give Us Pause?
-
Muted 6.7% annual revenue growth over the last five years shows its demand lagged behind its healthcare peers
-
Modest revenue base of $1.32 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
-
Low returns on capital reflect management’s struggle to allocate funds effectively
CONMED’s stock price of $57.68 implies a valuation ratio of 12.9x forward P/E. Check out our free in-depth research report to learn more about why CNMD doesn’t pass our bar .
Agilent (A)
Rolling One-Year Beta: 0.85
Originally spun off from Hewlett-Packard in 1999 as its measurement and analytical division, Agilent Technologies (NYSE:A) provides analytical instruments, software, services, and consumables for laboratory workflows in life sciences, diagnostics, and applied chemical markets.
Why Do We Think Twice About A?
-
Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
-
Anticipated sales growth of 4.1% for the next year implies demand will be shaky
-
Adjusted operating margin declined by 1.1 percentage points over the last two years as its sales cratered
At $108.63 per share, Agilent trades at 19x forward P/E. If you’re considering A for your portfolio, see our FREE research report to learn more .
One Stock to Watch:
Parsons (PSN)
Rolling One-Year Beta: 0.55
Delivering aerospace technology during the Cold War-era, Parsons (NYSE:PSN) offers engineering, construction, and cybersecurity solutions for the infrastructure and defense sectors.
Why Could PSN Be a Winner?
-
Annual revenue growth of 23.8% over the past two years was outstanding, reflecting market share gains this cycle
-
Operating profits and efficiency rose over the last five years as it benefited from some fixed cost leverage
-
Share buybacks catapulted its annual earnings per share growth to 35%, which outperformed its revenue gains over the last two years